Experience the Future of Healthcare with Doctronic Ready to take control of your health with the convenience and innovation of telehealth
Generic semaglutide shot available for Rs 1,290 per month: Top diabetologists welcome cost cut with a word of caution Cheaper generics promise wider access, yet specialists flag safety, storage and overuse concerns With nearly 50 brands of generic semaglutide set to launch in the Indian market on Saturday, doctors applaud the reduced cost and increased availability of the drug for their patients, along with a word of warning it is not meant for all, it should not be misused to lose those last five kilos
[1] [2] 1 mg per week The lowest tested dose, primarily intended to evaluate tolerability and establish baseline safety
GLP-1 Agonists: Understanding the Essentials (1.5 hours) CE/CME Course #: 25-395 This course provides essential clinical guidance on the prescribing, dosing, and administration of GLP-1 RAs, including key safety considerations such as warnings, precautions, and drug interactions
Not everyone with type 2 diabetes or obesity requires GLP-1 receptor agonist therapy
Muscle carnitine deficiency associated with zidovudine-induced mitochondrial myopathy